POST-MARKETING non-interventional safety evaluation of obizur in the treatment of bleeding episodes for patients with acquired hemophilia A
Clinical Trial Grant
Administered By
Medicine, Hematology
Awarded By
Baxalta, Inc.
Start Date
June 1, 2016
End Date
May 13, 2022
Administered By
Medicine, Hematology
Awarded By
Baxalta, Inc.
Start Date
June 1, 2016
End Date
May 13, 2022